# Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients

> **NCT01646255** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 346 (actual)

## Conditions studied

- Idiopathic Parkinson's Disease

## Interventions

- **DRUG:** Rotigotine
- **DRUG:** Placebo Patch
- **DRUG:** L-dopa

## Key facts

- **NCT ID:** NCT01646255
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 346 (ACTUAL)
- **Last updated:** 2018-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01646255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01646255, "Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01646255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*